KRT1 and head and neck squamous cell carcinoma: To investigate the role of KRT1 in tumor progression in vitro, KRT1-specific siRNA was used to inhibit the endogenous KRT1 expression in the SNU-1041 and PCl1 human HNSCC cell lines.